Neuronetics Clinical Trial To Evaluate Non-Drug NeuroStar TMS Therapy® in Adolescent Patients With MDD

Posted by TMS Solutions Staff on Nov 2, 2015 2:50:30 PM

Neuronetics Announces Launch of First Ever Randomized, Controlled Clinical Trial to Evaluate Non-Drug NeuroStar TMS Therapy® in Adolescent Patients with Major Depressive Disorder. This study will Examine Acute and Long-Term Benefits of NeuroStar TMS, Including Symptom Reduction and Remission Rates.

[Press Release: MALVERN, Pa., Nov. 2, 2015]

Read More

Topics: Neuronetics Press Release, Adolescent Patients With MDD